Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes.
Tare M, Kalidindi RS, Bubb KJ, Parkington HC, Boon WM, Li X, Sobey CG, Drummond GR, Ritchie RH, Kemp-Harper BK.
Tare M, et al. Among authors: boon wm.
Naunyn Schmiedebergs Arch Pharmacol. 2017 Apr;390(4):397-408. doi: 10.1007/s00210-016-1336-1. Epub 2017 Jan 10.
Naunyn Schmiedebergs Arch Pharmacol. 2017.
PMID: 28074232